Abstract: A surgical instrument (10) includes a housing (20) defining a longitudinal axis and a first assembly (200) and a second assembly (300) operably coupled to the housing (20). The first assembly (200) includes a first function button (200b) pivotably coupled to the housing (20) about a first pivot (200p) and a first circuit (210) supported by the housing (20) and aligned with the first pivot (200p). The first function button (200b) includes a first arm (201) on a first side of the first pivot (200p) and a second arm (202) on a second side of the first pivot (200p). The first circuit (210) is aligned with the cutting picot between the first arm (201) and the second arm (202) and includes a first actuator (211) on the first side of the first pivot (200p) and a second actuator (212) on the second side of the first pivot (200p).

Abstract: The present disclosure relates to a method for producing vinyl acetate, comprising a vinyl acetate synthesis process, a vinyl acetate refining process and a separation process of vinyl acetate and ethyl acetate, including an acetic acid evaporator, an oxygen mixer, a vinyl acetate synthesis reactor, a first gas separating tower, a second gas separating tower, a recovered gas compressor, a water washing tower, an absorption tower and a desorption tower, a recycling gas compressor; the vinyl acetate refining process comprising an acetic acid tower, a crude VAC tower, and a fine VAC tower, a rectifying tower, an ethyl acetate tower, a water phase receiving tank, an extracting and rectifying tower and an ethyl acetate phase separator.

Abstract: The present invention relates to an anticancer drug, an energized fusion protein Anti-CD20(Fab)-LDM of lidamycin, a gene encoding the same; and further relates to a method for construction of the energized fusion protein in a genetic engineering manner and the use of the energized fusion protein. The applicant provides an anti-tumor drug with a good targeting ability by providing the energized fusion protein.